Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 5

Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis

Total article views   HTML views PDF downloads Totals
4,708 Dovepress* 4,708+ 1,642 6,350
Totals 4,708 1,642 6,350
*Since 15 November 2007
+Since July 2016

View citations on Google Scholar